Stockreport

Coloplast - Premium Valuation And Pedestrian Results Have Been A Bad Mix [Seeking Alpha]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF CLPBY's CEO search remains unresolved, and rebuilding investor confidence may take longer than bulls anticipate despite a 30% share price decline. Growth in the U.S. [Read more]